Marini et al., therefore, conducted a 2-year randomized trial of genistein versus placebo in 389 osteopenic postmenopausal women. The authors conclude that genistein improves BMD and bone-turnover ...

I was somewhat shocked to discover that my bone mineral density had dropped so much that I was now in the osteopenic range, ...

In this study, alendronate reduced vertebral fracture rates among osteopenic postmenopausal women. However, the absolute benefit was very small among women without vertebral fractures at baseline.